Market: NMS |
Currency: USD
Address: 4400 Route 9 South
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights. The company was founded in 2016 and is headquartered in Freehold, New Jersey.
📈 Avalon GloboCare Corp. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Avalon GloboCare Corp.
No earnings history available for this symbol.
📰 Related News & Research
-
Avalon GloboCare Corp. Files Form 8-K Current Report with SEC – April 1, 2026
April 1, 2026
Avalon GloboCare Corp. 8-K Report: Key Investor Update ...
-
Avalon GloboCare Corp. Announces $2.8 Million Private Placement to Support Operating Expenses and Working Capital 11
March 25, 2026
Avalon GloboCare Corp. Amends 8-K Filing to Correct Share Is...
-
Avalon GloboCare Corp. 8-K Filing Details: Company Info, Stock Symbol ALBT, and NASDAQ Listing
March 11, 2026
Avalon Globocare Corp. Form 8-K Report - March 4, 2026 ...
-
Avalon GloboCare Corp. (ALBT) Announces $207,000 Securities Purchase Agreement with Vanquish Funding Group Inc. on February 19, 2026
February 26, 2026
Avalon GloboCare Corp. 8-K Filing: Detailed Investor Analysi...
-
Avalon GloboCare Corp. Amended and Restated Membership Interest Purchase Agreement with Wenzhao Lu – 8-K Filing Details and XBRL Data
February 20, 2026
Avalon GloboCare Corp. Announces Completion of Material Asse...
🔍 View more Reports
